Scientists find new way to mobilize immune system against viruses

New research could help in the fight against viral pandemics such as the 2002 SARS outbreak, which led many to wear surgical masks. Credit: Kurt Groetsch, Flickr.

University of British Columbia scientists have uncovered an intricate chain reaction in the body's immune system and have used the knowledge to develop a new treatment against harmful viruses.

Viral pandemics, such as the coronavirus that caused the deadly SARS outbreak in 2002, have caused hundreds of deaths in Canada, yet effective anti-viral drugs are rare.

A key element to this natural immune response is an antiviral protein in the blood called Interferon alpha. Like soldiers, Interferon alpha is quickly deployed by the body to fight viruses and removed just as quickly to restore equilibrium.

As described in the current issue of the prestigious journal Nature Medicine, a team led by Overall from UBC's Department of Oral Biological and Medical Sciences and Bruce McManus from UBC's Department of Pathology and Laboratory Medicine has discovered that an enzyme called MMP12 serves double-duty in the deployment of the critical antiviral protein: it first enters the infected cell to activate Interferon alpha and then sends it outside the to fight viruses. After the job of Interferon alpha is done, MMP12 dissolves the protein during the healing process.

Overall has developed a new antiviral drug that blocks MMP12 from dissolving Interferon alpha outside the cell, giving the an added boost by keeping levels of the protein high in the bloodstream. The drug cannot penetrate cell membranes, making it unable to interfere with the beneficial work inside the cell. The drug has been shown to effectively treat viral infections in mice models and holds promise as a new broad-spectrum antiviral treatment.

"Because the drug isn't virus-strain specific and boosts the body's own to fight infections, it could be effective for even emergent, unknown viruses and eliminate the lag time required to first identify and sequence the virus genetic material before we can treat it," says Overall.

More information: Paper: www.nature.com/nm/journal/vaop… 3508.html#affil-auth

add to favorites email to friend print save as pdf

Related Stories

Study reveals natural process that blocks viruses

Apr 17, 2013

The human body has the ability to ward off viruses by activating a naturally occurring protein at the cellular level, setting off a chain reaction that disrupts the levels of cholesterol required in cell membranes to enable ...

Recommended for you

Study unlocks basis of key immune protein's two-faced role

Nov 26, 2014

A Brigham and Women's Hospital-led team has identified a long sought-after partner for a key immune protein, called TIM-3, that helps explain its two-faced role in the immune system—sometimes dampening it, other times stimulating ...

Profilin can induce severe food-allergic reactions

Nov 25, 2014

(HealthDay)—Profilins are complete food allergens in food-allergic patient populations that are exposed to high levels of grass pollen, according to a study published in the December issue of Allergy.

Structured education program beneficial for anaphylaxis

Nov 21, 2014

(HealthDay)—A structured education intervention improves knowledge and emergency management for patients at risk for anaphylaxis and their caregivers, according to a study published online Nov. 19 in Allergy.

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.